Abstract #4352

Magnetic Resonance Spectroscopic Early Predictors of 2-Year Progression Free Survival in IDH Mutated WHO II and III Gliomas

Min Zhou¹, Raymond Huang², Huijun Liao¹, Benjamin Rowland¹, Yue Zhou¹, Nils Arvold³, and Alexander Lin¹

¹Center for Clinical Spectroscopy, Brigham and Women's Hospital, Boston, MA, United States, ²Radiology, Brigham and Women's Hospital, Boston, MA, United States, ³Radiation Oncology, Brigham and Women's Hospital, Boston, MA, United States

Most MR spectroscopy studies of patients with IDH-mutated gliomas have focused on the sensitivity and specificity of the 2-hydroxyglutarate measures but none that have examined the predictive value of 2HG in comparison to other brain metabolites for treatment outcome. This prospective longitudinal study measured MRS at baseline and two time points after radio/chemotherapy of IDH-mutated gliomas. Results showed that Cho/NAA shows the greatest predictive value followed by Cho/Cr, NAA/Cr, and Lac/Cr ratios but that all three time points 2HG levels were not predictive of outcome demonstrating that it is likely reflective of pathways distinct from membrane proliferation.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.